Medical Disposables Market is set to grow significantly from 2023 to 2032 driven by the ongoing transition from the use of reusable medical equipment to disposable medical supplies to reduce the risk of cross-contamination and surgical-site infections. In addition, the growing use of bioplastics to reduce the environmental impact of the healthcare industry will boost the usage of biodegradable medical supplies and disposables by 2032.
Medical disposables refer to systems intended to be used once or temporarily to render quality patient care. These single-use products include gloves, blood bags, needles, and face masks, which can replace conventional equipment that involves a costly and time-consuming sterilization procedure.
The high incidence rate of chronic conditions and the subsequent increase in the rate of hospitalizations are some of the factors bolstering overall medical disposables market performance by 2032. Furthermore, the escalating prevalence of hospital-acquired infections is also likely to enhance industry dynamics. However, the market is set to witness challenges owing to rising inflation, which will negatively impact medical disposables production. Additionally, growing concerns regarding environmental pollution associated with the usage of disposable masks will adversely affect the business revenue in the coming years.
Based on product, the surgical instruments and supplies segment is projected to hold a considerable share of the medical disposables market by 2032 due to rapid technological advancements and the growing acceptance of minimally invasive treatment worldwide, which is amplifying the deployment of disposable surgical gloves and other products. The segment expansion will further be driven by the increasing reliance on ambulatory surgical centers (ASC) to perform outpatient surgery.
In terms of end-use, the medical disposables industry from the hospital segment is poised to record sizeable expansion through 2032 due to the mounting number of patient admissions in hospitals for surgeries and treatments. Moreover, the onset of the COVID-19 pandemic has impelled the need for disposable medical products to limit the spread of the disease. As a result, the increasing utilization of medical disposables in hospitals is anticipated to spur segment outlook over the estimated timeline.
As per region, the Asia Pacific medical disposables market will amass substantial profits by 2032 on account of the increased health spending despite the lower fiscal revenue during the COVID-19 pandemic in emerging economies such as China. This, along with the growing elderly population and the high burden of chronic diseases, will also serve as major factors propelling the regional market development over the forecast timespan.
Prominent players in the market include 3M Company, Smiths Medical (ICU Medical), STERIS plc, Smith & Nephew, Johnson & Johnson, Terumo Medical Corporation, Cardinal Health, Boston Scientific, ConvaTec Inc., B. Braun, Boston Scientific, Baxter International Inc., Kimberly-Clark Corporation, Medline Industries, Inc., Abbott Laboratories, Ansell Limited, Ahlstrom-Munksjo, and Gerresheimer AG, among others.